Open AccessThe efficacy low dose of prednisolone in the treatment of hyperemesis gravidarum
Author(s) -
Ziaei Saeideh,
Hosseiney Fatima Sadat,
Faghihzadeh Soghrate
Publication year - 2004
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.1111/j.0001-6349.2004.0141.x
Subject(s) - hyperemesis gravidarum , medicine , prednisolone , nausea , vomiting , promethazine , dose , anesthesia , antiemetic , pregnancy , biology , genetics
Background. To determine whether low dosages of prednisolone are effective in the treatment of outpatients with hyperemesis gravidarum. Methods. Eighty pregnant women with gestational ages of 6 to 12 weeks and persistent nausea and vomiting participated. The women were assigned by simple randomization to receive prednisolone 5 mg daily or promethazine 75 mg daily by oral route for 10 days. The severity of nausea, frequency of vomiting per day, sickness and the drugs' side‐effects were compared (Fisher's exact test, Mann–Whitney U ‐test, Odds Ratio test). Results. The women who received promethazine responded better in the first 48 h ( p = 0.02). With continuation of the treatment, the difference decreased, and one week after completion of the treatment, the subjects who had received prednisolone had less symptoms. Conclusion. Promethazine reduces the symptoms of hyperemesis gravidarum faster than prednisolone, but during prolonged treatment, prednisolone has at least the same effects on the symptoms and less drug side‐effects.